DAFNA Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.71M | Buy |
879,163
+147,800
| +20% | +$961K | 1.58% | 16 |
|
|
2025
Q1 | $5.8M | Hold |
731,363
| – | – | 1.64% | 16 |
|
|
2024
Q4 | $9.27M | Sell |
731,363
-19,000
| -3% | -$241K | 2.36% | 14 |
|
|
2024
Q3 | $10.5M | Buy |
750,363
+83,900
| +13% | +$1.17M | 2.47% | 13 |
|
|
2024
Q2 | $9.18M | Hold |
666,463
| – | – | 2.19% | 16 |
|
|
2024
Q1 | $11M | Sell |
666,463
-20,000
| -3% | -$330K | 2.51% | 12 |
|
|
2023
Q4 | $10M | Buy |
686,463
+100,000
| +17% | +$1.46M | 2.4% | 13 |
|
|
2023
Q3 | $7.2M | Buy |
586,463
+79,363
| +16% | +$974K | 2.24% | 13 |
|
|
2023
Q2 | $6.05M | Buy |
+507,100
| New | +$6.05M | 1.66% | 19 |
|